Comparisons › DHR / IDXX
Danaher vs Idexx Laboratories: comparing DHR and IDXX stock
12-month growth, from 100━ DHR +7.0% ━ IDXX −6.9%
| Metric | DHR | IDXX |
|---|---|---|
| Price, $ | 226.34 | 670.71 |
| Year to date | −0.9% | −0.9% ● |
| 12 months | +7.0% ● | −6.9% |
| From 52-week high | −6.6% ● | −12.9% |
| vs 200-day average | +12.7% | +17.2% ● |
| P/E | 27.1 | 45.2 |
| Dividend yield | 0.69% ● | 0.00% |
| Revenue growth, YoY | +5.5% | +11.9% ● |
| Operating income growth | +7.1% | +16.8% ● |
| Operating margin | 22.0% | 32.5% ● |
| Gross margin | 59.4% | 62.7% ● |
| Market cap | $159.2B | $52.8B |
| Next earnings | Jan 27, 2027 | Feb 8, 2027 |
● — whose figure is higher, not which is better. Data as of Nov 5, 2026.
Ratings and a detailed chart for each are in the terminal.
Open the terminalFAQ
Which is better to buy: Danaher or Idexx Laboratories?
We do not advise what to buy. By the numbers: Danaher rose more over the year (+7.0%); Danaher is closer to its 52-week high; Idexx Laboratories has the higher operating margin; Idexx Laboratories is growing revenue faster; Danaher has the lower P/E. How to weigh such signs is covered in «How to analyse a stock».
Can I buy both?
Yes. Many hold several companies in one industry to avoid depending on one. A broad index fund often already holds the largest US companies.
When do they report?
Danaher — Jan 27, 2027; Idexx Laboratories — Feb 8, 2027.